Latest news
Insiders In BioCardia Still Down 21% On US$1.08m Investment - simplywall.stsimplywall.st · Thu, 06 Aug 2026 10:26:09 GMTLegend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap? - SahmSahm · Thu, 30 Jul 2026 07:00:00 GMTInsiders In Kane Biotech Still Down 40% On CA$1.70m Investment - simplywall.stsimplywall.st · Tue, 28 Jul 2026 07:00:00 GMTAlnylam’s stock is down 30% despite a booming biotech market. Here’s why - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMT